Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03829722
Title Radiotherapy, Carboplatin/Paclitaxel and Nivolumab for High Risk HPV-related Head and Neck Cancer
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors University of Michigan Rogel Cancer Center

oral squamous cell carcinoma

soft palate cancer

tongue squamous cell carcinoma

oropharynx cancer

tonsil squamous cell carcinoma


Carboplatin + Nivolumab + Paclitaxel

Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST